Evaluation of the Effect of the Gel on Sensitive Teeth

May 18, 2026 updated by: Lacer S.A.

Evaluation of the Efficacy of a Product for Oral Care in Use Test Under Dentist Control.

The goal of this study is to learn if a tooth gel works to alleviate teeth hypersensitivity in adults. It will also learn about the safety of the product.

The main question it aims to answer is:

• Does the tooth gel help to improve signs of teeth hypersensitivity?

Researchers will compare before and after product use to see if it works to improve teeth sensitivity. Participants will:

  • Use assigned products daily for 14 days
  • Visit the clinic on the established days during 14 days for check-ups and evaluation

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain
        • CLINICA CIURANA Centre Dental

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy female and male subjects (no specific repartition)
  • Aged between 18 years old
  • Subjects with dentine hyperesthesia
  • Have a minimum of two hypersensitive teeth anterior to non-consecutive molars, with cervical erosion/abrasion or gingival recession, and with a grade greater than or equal to 1 on the verbal rating scale (VRS) after tactile simulation, and greater than or equal to 1 on the Schiff cold air sensitive scale at the beginning of the study.
  • Subjects certifying the truthfulness of the personal data disclosed to the investigator
  • Subjects able to understand the language used in the investigation canter and the information given by the investigator
  • Subjects able to respect the instructions given by the investigator as well as able to respect the study constraints and specific requirements
  • The pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) should be stable for at least one month without any changes expected or planned during the study
  • Commitment not to change the daily routine or the lifestyle
  • Subjects who have not been recently involved in any other similar study
  • Commitment not to use during the study period other products with the same effect of the tested product
  • Subjects informed about the test procedures and who have signed a consent form.

Exclusion Criteria:

  • Subjects participating or planning to participate in other clinical trials;
  • Subjects deprived of liberty by administrative or judicial decision or under guardianship;
  • Subjects who cannot be contacted in an emergency;
  • Subjects admitted to a health or social center;
  • Subjects planning hospitalization during the study;
  • Subjects who participated in a similar study without respecting an adequate washout period (used any desensitizing agents during the last three months);
  • Subjects who have used anti sensitivity products in the 4 weeks prior to screening;
  • Subjects under pharmacological treatments that the investigator considers incompatible with the requirements of the study;
  • Subjects who have had active caries within 12 months or who are at risk of caries development (multiple dental restorations, crowns with compromised margin) per examiners discretion;
  • Subjects who have shown allergies or sensitivity to any component of the product;
  • Subject breastfeeding, pregnant or not willing to take the necessary precautions to avoid pregnancy during the study (for women of childbearing age).
  • Any tooth surface adjacent to those surfaces under investigation, which in the opinion of the investigator have any other condition that provides symptoms confusing with those of cervical dentin hypersensitivity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Desensitizing tooth gel
Desensitizing tooth gel was used 3 times a day after meals during 14 days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in teeth sensitivity to cold air at 14 days.
Time Frame: From enrolment to the end of use at 14 days.
Change evaluated by VAS score scale from 0 to 3, where 0 means the absence of pain while 3 is the highest pain.
From enrolment to the end of use at 14 days.
Change from Baseline in teeth sensitivity to periodontal probe at 14 days
Time Frame: From enrolment to the end of use at 14 days.
Change evaluated by VAS score scale: from 0 to 10, where 0 means the absence of pain while 10 is the highest pain
From enrolment to the end of use at 14 days.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 8, 2024

Primary Completion (Actual)

July 31, 2024

Study Completion (Actual)

July 31, 2024

Study Registration Dates

First Submitted

May 12, 2026

First Submitted That Met QC Criteria

May 18, 2026

First Posted (Actual)

May 19, 2026

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ES0000257/24

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Only summary of the results to support the publication will be shared. No complete study documents will be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dentine Sensitivity

Clinical Trials on Desensitizing tooth gel

Subscribe